Literature DB >> 23911704

Nucleosomes and neutrophil activation in sickle cell disease painful crisis.

Marein Schimmel1, Erfan Nur, Bart J Biemond, Gerard J van Mierlo, Shabnam Solati, Dees P Brandjes, Hans-Martin Otten, John-John Schnog, Sacha Zeerleder.   

Abstract

Activated polymorphonuclear neutrophils play an important role in the pathogenesis of vaso-occlusive painful sickle cell crisis. Upon activation, polymorphonuclear neutrophils can form neutrophil extracellular traps. Neutrophil extracellular traps consist of a meshwork of extracellular DNA, nucleosomes, histones and neutrophil proteases. Neutrophil extracellular traps have been demonstrated to be toxic to endothelial and parenchymal cells. This prospective cohort study was conducted to determine neutrophil extracellular trap formation in sickle cell patients during steady state and painful crisis. As a measure of neutrophil extracellular traps, plasma nucleosomes levels were determined and polymorphonuclear neutrophil activation was assessed measuring plasma levels of elastase-α1-antitrypsin complexes in 74 patients in steady state, 70 patients during painful crisis, and 24 race-matched controls using Enzyme Linked Immunosorbent Assay. Nucleosome levels in steady state sickle cell patients were significantly higher than levels in controls. During painful crisis levels of both nucleosomes and elastase-α1-antitrypsin complexes increased significantly. Levels of nucleosomes correlated significantly to elastase-α1-antitrypsin complex levels during painful crisis, (Sr = 0.654, P<0.001). This was seen in both HbSS/HbSβ(0)-thalassemia (Sr=0.55, P<0.001) and HbSC/HbSβ(+-)thalassemia patients (Sr=0.90, P<0.001) during painful crisis. Levels of nucleosomes showed a correlation with length of hospital stay and were highest in patients with acute chest syndrome. These data support the concept that neutrophil extracellular trap formation and neutrophil activation may play a role in the pathogenesis of painful sickle cell crisis and acute chest syndrome.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23911704      PMCID: PMC3815182          DOI: 10.3324/haematol.2013.088021

Source DB:  PubMed          Journal:  Haematologica        ISSN: 0390-6078            Impact factor:   9.941


  48 in total

Review 1.  The key role of nucleosomes in lupus.

Authors:  Z Amoura; J C Piette; J F Bach; S Koutouzov
Journal:  Arthritis Rheum       Date:  1999-05

Review 2.  Beneficial suicide: why neutrophils die to make NETs.

Authors:  Volker Brinkmann; Arturo Zychlinsky
Journal:  Nat Rev Microbiol       Date:  2007-08       Impact factor: 60.633

3.  Peripheral blood neutrophil count and candidacidal activity correlate with the clinical severity of sickle cell anaemia (SCA)

Authors:  C C Anyaegbu; I E Okpala; Y A Akren'Ova; L S Salimonu
Journal:  Eur J Haematol       Date:  1998-04       Impact factor: 2.997

4.  Neutrophil activation in sickle cell disease.

Authors:  L R Lard; F P Mul; M de Haas; D Roos; A J Duits
Journal:  J Leukoc Biol       Date:  1999-09       Impact factor: 4.962

5.  Blood polymorphonuclear leukocytes from the majority of sickle cell patients in the crisis phase of the disease show enhanced adhesion to vascular endothelium and increased expression of CD64.

Authors:  E Fadlon; S Vordermeier; T C Pearson; A R Mire-Sluis; D C Dumonde; J Phillips; K Fishlock; K A Brown
Journal:  Blood       Date:  1998-01-01       Impact factor: 22.113

6.  Hydroxyurea and sickle cell anemia. Clinical utility of a myelosuppressive "switching" agent. The Multicenter Study of Hydroxyurea in Sickle Cell Anemia.

Authors:  S Charache; F B Barton; R D Moore; M L Terrin; M H Steinberg; G J Dover; S K Ballas; R P McMahon; O Castro; E P Orringer
Journal:  Medicine (Baltimore)       Date:  1996-11       Impact factor: 1.889

7.  Activated neutrophil-mediated sickle red blood cell adhesion to lung vascular endothelium: role of phosphatidylserine-exposed sickle red blood cells.

Authors:  Johnson Haynes; Boniface Obiako; Judy A King; Raymond B Hester; Solomon Ofori-Acquah
Journal:  Am J Physiol Heart Circ Physiol       Date:  2006-05-19       Impact factor: 4.733

8.  Intravenous immunoglobulins reverse acute vaso-occlusive crises in sickle cell mice through rapid inhibition of neutrophil adhesion.

Authors:  Jungshan Chang; Patricia A Shi; Elaine Y Chiang; Paul S Frenette
Journal:  Blood       Date:  2007-10-11       Impact factor: 22.113

9.  Circulating DNA: a potential marker of sickle cell crisis.

Authors:  Nisha Vasavda; Pinar Ulug; Sheila Kondaveeti; Karthik Ramasamy; Taku Sugai; Gordon Cheung; David C Rees; Moji Awogbade; Sybil Bannister; Juliette Cunningham; Stephan Menzel; Swee Lay Thein
Journal:  Br J Haematol       Date:  2007-10       Impact factor: 6.998

10.  The humoral pattern recognition receptor PTX3 is stored in neutrophil granules and localizes in extracellular traps.

Authors:  Sébastien Jaillon; Giuseppe Peri; Yves Delneste; Isabelle Frémaux; Andrea Doni; Federica Moalli; Cecilia Garlanda; Luigina Romani; Hugues Gascan; Silvia Bellocchio; Silvia Bozza; Marco A Cassatella; Pascale Jeannin; Alberto Mantovani
Journal:  J Exp Med       Date:  2007-03-26       Impact factor: 14.307

View more
  27 in total

Review 1.  Targeting novel mechanisms of pain in sickle cell disease.

Authors:  Huy Tran; Mihir Gupta; Kalpna Gupta
Journal:  Blood       Date:  2017-11-30       Impact factor: 22.113

Review 2.  Pathophysiology of Sickle Cell Disease.

Authors:  Prithu Sundd; Mark T Gladwin; Enrico M Novelli
Journal:  Annu Rev Pathol       Date:  2018-10-17       Impact factor: 23.472

3.  Heme-induced neutrophil extracellular traps contribute to the pathogenesis of sickle cell disease.

Authors:  Grace Chen; Dachuan Zhang; Tobias A Fuchs; Deepa Manwani; Denisa D Wagner; Paul S Frenette
Journal:  Blood       Date:  2014-03-11       Impact factor: 22.113

Review 4.  Extracellular histones in tissue injury and inflammation.

Authors:  Ramanjaneyulu Allam; Santhosh V R Kumar; Murthy N Darisipudi; Hans-Joachim Anders
Journal:  J Mol Med (Berl)       Date:  2014-04-06       Impact factor: 4.599

Review 5.  Sickle cell disease: a malady beyond a hemoglobin defect in cerebrovascular disease.

Authors:  Junaid Ansari; Youmna E Moufarrej; Rafal Pawlinski; Felicity N E Gavins
Journal:  Expert Rev Hematol       Date:  2017-12-05       Impact factor: 2.929

Review 6.  Targeting novel mechanisms of pain in sickle cell disease.

Authors:  Huy Tran; Mihir Gupta; Kalpna Gupta
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2017-12-08

7.  End points for sickle cell disease clinical trials: patient-reported outcomes, pain, and the brain.

Authors:  Ann T Farrell; Julie Panepinto; C Patrick Carroll; Deepika S Darbari; Ankit A Desai; Allison A King; Robert J Adams; Tabitha D Barber; Amanda M Brandow; Michael R DeBaun; Manus J Donahue; Kalpna Gupta; Jane S Hankins; Michelle Kameka; Fenella J Kirkham; Harvey Luksenburg; Shirley Miller; Patricia Ann Oneal; David C Rees; Rosanna Setse; Vivien A Sheehan; John Strouse; Cheryl L Stucky; Ellen M Werner; John C Wood; William T Zempsky
Journal:  Blood Adv       Date:  2019-12-10

Review 8.  Coagulation abnormalities of sickle cell disease: Relationship with clinical outcomes and the effect of disease modifying therapies.

Authors:  Denis Noubouossie; Nigel S Key; Kenneth I Ataga
Journal:  Blood Rev       Date:  2015-12-24       Impact factor: 8.250

Review 9.  Red cell DAMPs and inflammation.

Authors:  Rafaela Mendonça; Angélica A A Silveira; Nicola Conran
Journal:  Inflamm Res       Date:  2016-06-01       Impact factor: 4.575

10.  Inflammation in sickle cell disease.

Authors:  Nicola Conran; John D Belcher
Journal:  Clin Hemorheol Microcirc       Date:  2018       Impact factor: 2.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.